Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Vancomycin.php on line 2
Vancomycin
LE WE PMID CA
Vancomycin2865Vancomycin

Erythromycin

Teicoplanin

Vancomycin

2008  
1
Vancomycin: understanding its past and preserving its future.
[18364659] South Med J 101(3): 284-91 (2008)
2002  
2
Clinical review: use of vancomycin in haemodialysis patients.
[12225605] Crit Care 6(4): 313-6 (2002)
1991  
3
Antibacterial activities and modes of action of vancomycin and related glycopeptides.
[2069366] Antimicrob Agents Chemother 35(4): 605-9 (1991)
1989  
4
Vancomycin- and erythromycin-induced hearing loss in humans.
[2669623] Antimicrob Agents Chemother 33(6): 791-6 (1989)
1996  
5
The comparative efficacy and safety of teicoplanin and vancomycin.
[8707731] J Antimicrob Chemother 37(2): 209-22 (1996)
1995  
6
Current perspectives on glycopeptide resistance.
[8665471] Clin Microbiol Rev 8(4): 585-615 (1995)
1990  
7
Resistance to vancomycin and teicoplanin: an emerging clinical problem.
[2143434] Clin Microbiol Rev 3(3): 280-91 (1990)
2003  
8
Vancomycin use in hospitalized pediatric patients.
[12897315] Pediatrics 112(2): e104-11 (2003)
2010  
9
Vancomycin-associated nephrotoxicity: grave concern or death by character assassination?
[20103028] Am J Med 123(2): 182.e1-7 (2010)
2010  
10
Guidelines for vancomycin use.
[20095836] Clin Infect Dis 50(4): 616 (2010)
2009  
11
Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists.
[19569969] Clin Infect Dis 49(3): 325-7 (2009)
2002  
12
Vancomycin resistance in staphylococci.
[12097250] Clin Microbiol Rev 15(3): 430-8 (2002)
2010  
13
Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications.
[20065327] Clin Microbiol Rev 23(1): 99-139 (2010)
2010  
14
Use of vancomycin pharmacokinetic-pharmacodynamic properties in the treatment of MRSA infections.
[20014904] Expert Rev Anti Infect Ther 8(1): 95-106 (2010)
2011  
15
Vancomycin nephrotoxicity: myths and facts.
[21978980] Neth J Med 69(9): 379-83 (2011)
2010  
16
Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society Of Infectious Diseases Pharmacists.
[20179794] Clin Biochem Rev 31(1): 21-4 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Vancomycin.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Vancomycin.php on line 92